© 2020 MJH Life Sciences and HCPLive. All rights reserved.
May 26, 2020
Social isolation could increase risk for cardiovascular events by 40%, according to new research presented at EAN 2020 Virtual Congress.
May 21, 2020
A new analysis of the DASH trial found a fruit-and-vegetable diet was associated with lower levels of hs-cTnl and NT-proBNP.
September 02, 2019
A study presented at ESC Congress 2019 found that anabolic-androgenic steroid use in male weightlifters can lead to thickening of the heart muscle and reduced ejection fraction
August 31, 2019
Updated guidelines for the treatment and diagnosis of chronic coronary diseases were released by the European Society of Cardiology at ESC Congress 2019 in Paris.
April 27, 2019
Data from ACC 2018 showed the PCSK9 inhibitor is associated with an absolute risk reduction of 1.6% in treated patients versus placebo.
April 08, 2019
Investigators have found that despite improvements in women’s cardiovascular health care, black women still face disparities in care compared to white and Hispanic women.
April 02, 2019
A new study finds it is safe for patients who undergo heart stent procedures to quit taking aspirin at 3 months so long as they continue taking a P2Y12 inhibitor.
November 14, 2018
James Januzzi, MD, discusses trial results from the PIONEER-HF trial and what cardiologists and hospitalists should know about sacubitril-valsartan.
November 13, 2018
Steven Nissen, MD, discusses the updates to the cholesterol guidelines and how the risk calculator should not be considered an end-all be-all.
“These guidelines bring back the concept of adjusting therapy for cholesterol levels, and they recommend more aggressive treatment targets for people in very high risk,” said Cleveland Clinic’s Steven Nissen.